Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival
Lussow, A.R.; Fanget, L.; Gao, L.; Buelow, R.; Pouletty, P.
Transplantation Proceedings 28(2): 571-572
1996
ISSN/ISBN: 0041-1345 PMID: 8623277 Document Number: 466357
Document emailed within 1 workday
Related Documents
Ramos, T.; Möller, E. 1981: Correlation between suppression of B cell anti-hapten response and generation of cytotoxic T cells induced by hapten-labelled syngeneic lymphocytes Scandinavian Journal of Immunology 13(2): 119-125Henry, M.L.; Bendle, M.D. 1996: Donor graft perfusion pre-transplant prolongs xenograft survival Transplantation Proceedings 28(2): 595
Itaya, T. 1981: Cytotoxic natural anti-tumor antibodies against fibrosarcoma and glioma cells in rats Hokkaido Journal of Medical Science 56(5): 499-506
Eriksson, T.; Riesbeck, K.; Ostraat, O.; Ekberg, H.; Björkman, S. 1992: Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival Transplantation Proceedings 24(6): 2560-2561
Lauria, F.; Raspadori, D.; Rondelli, D.; Ventura, M.A.; Foà, R. 1994: In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival Leukemia 8(5): 724-728
Holley, J.L.; Mather, A.; Wheelhouse, R.T.; Cullis, P.M.; Hartley, J.A.; Bingham, J.P.; Cohen, G.M. 1992: Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate Cancer Research 52(15): 4190-4195
Ortega, G.; Robb, R.J.; Shevach, E.M.; Malek, T.R. 1984: The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells Journal of Immunology 133(4): 1970-1975
Levy, R.B.; Richardson, J.C.; Margulies, D.H.; Evans, G.A.; Seidman, J.G.; Ozato, K. 1983: The products of transferred H-2 genes express determinants that restrict hapten-specific cytotoxic T cells Journal of Immunology 130(6): 2514-2518
Richards, A.L.; Okuno, T.; Takagaki, Y.; Djeu, J.Y. 1988: Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF Journal of Immunology 141(9): 3061-3066
Arora, P.K.; Shearer, G.M. 1981: Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells Journal of Immunology 127(5): 1822-1828
Chen, S.; Cerny, J. 1980: Studies on hapten-specific B cell tolerance in vitro. II. Regulation of central tolerance in T-independent B cells by antigen-activated syngeneic T cells Journal of Immunology 125(5): 1970-1976
Waksal, S.D.; Borel, Y. 1980: The influence of hapten-conjugated isologous mouse gamma-globulin as a tolerogen on H-2 restricted cytotoxic effector cells Journal of Immunology 124(3): 1506-1509
Klein, S.C.; van der Burg, S.H.; Boer, L.H.; Melief, C.J.; Kast, W.M.; de Gast, G.C.; Bast, E.J. 1997: Targeting of cytotoxic T cells against leukemic B cells by bispecific antibody (aCD3 x aCD19) does not distract the T cell from its primary target Journal of Immunology 159(11): 5545-5549
Blakely, M.L.; Van der Werf, W.J.; Stuhlmeier, K.; Dalmasso, A.P.; Winkler, H.; Bach, F.H. 1994: Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival Transplantation Proceedings 26(3): 1176
Poltorak, M.; Logan, S.; Freed, W.J. 1989: Intraventricular xenografts: chronic injection of antibodies into the CSF provokes granulomatosis reactions but Ia antibodies do not enhance graft survival Regional Immunology 2(4): 197-202
Clancy, J.Jr; Goral, J.; Triner, J.; Ellis, T. 1987: Increased activation of yac 1 killers natural killers nk versus daudi killers lymphokine activated killers lak by spleen cells from control and acute graft versus host disease agvhd rats by recombinant il 2 ril 2 Anatomical Record 218(1): 25A
Itoh, K.; Tilden, A.B.; Balch, C.M. 1985: Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells Cancer Research 45(7): 3173-3178
Law, K.Seng.; Chen, H-Chang.; Liao, S-Kuei. 2007: Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells Anticancer Research 27(2): 841-850
Dupouey, P. 1972: Antigenic structure of Treponema: demonstration of a new lipid hapten in "Treponema reiteri". Study of human serums containing antibodies against this hapten Annales de l'Institut Pasteur 122(2): 283-295
Kuroda, K.; Yagi, J.; Imanishi, K.; Yan, X.J.; Li, X.Y.; Fujimaki, W.; Kato, H.; Miyoshi-Akiyama, T.; Kumazawa, Y.; Abe, H.; Uchiyama, T. 1996: Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen Journal of Immunology 157(4): 1422-1431